510(k) K140029

AMIPLIVUE HSV 1&2 ASSAY by Quidel Corporation — Product Code OQO

K140029 is an FDA 510(k) premarket notification submitted by Quidel Corporation for the device "AMIPLIVUE HSV 1&2 ASSAY". The FDA issued a decision of Substantially Equivalent on March 26, 2014. The device falls under product code OQO (Herpes Simplex Virus Nucleic Acid Amplification Assay), a Class II device regulated under 21 CFR 866.3305. Quidel Corporation has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
March 26, 2014
Date Received
January 6, 2014
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Herpes Simplex Virus Nucleic Acid Amplification Assay
Device Class
Class II
Regulation Number
866.3305
Review Panel
MI
Submission Type

A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.